HMP 1991012

Drug Profile

HMP 1991012

Alternative Names: HMP 12

Latest Information Update: 23 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Molecular Design International
  • Class
  • Mechanism of Action Alpha adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Erectile dysfunction; Female sexual dysfunction

Most Recent Events

  • 23 Sep 2002 Preclinical trials in Female sexual dysfunction in USA (unspecified route)
  • 08 Oct 2001 Preclinical development for Erectile dysfunction in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top